Skip to main content

Table 2 Methodological quality of included studies based on the Newcastle–Ottawa scale

From: The prevalence and risk factors of sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

Studies (n = 28)

Selection(0–4stars)

Comparability (0–2 stars)

Outcome (0–3 stars)a,b

Total NOS score (0–9)

Tanaka 2015

***

*

**

6

Wang 2016

***

*

*

5

Murata 2017

***

*

**

6

Bouchi 2017

**

*

**

5

Trierweiler 2018

***

**

**

7

Murai 2018

****

*

***

8

Hashimoto 2018

***

*

**

6

Yanagita 2019

****

**

**

8

Okamura 2019

****

*

**

7

Ken 2019

****

**

**

8

Kaji 2019

****

*

**

7

Noriko 2019

****

*

**

7

Fung 2019

****

*

***

8

Takahashi 2020

****

**

***

9

Sung 2020

**

**

**

6

Seo 2020

**

*

***

6

Pechmann 2020

****

**

**

8

Nakanishi 2020

***

**

**

8

Mori 2020

****

**

**

8

Beretta 2020

***

*

*

5

Sazlina 2020

***

*

*

5

Jung 2020

****

**

***

9

Gorial 2020

**

*

**

5

Mauren 2020

****

**

**

8

Cui 2020

****

*

**

7

Chen 2020

***

*

**

6

Ken 2021

****

**

***

9

Kang 2021

****

**

**

8

  1. A study can be awarded a maximum of one star for each numbered item within the Selection and Exposure categories and maximum of two stars can be given for comparability
  2. aA cohort study with a follow-up time > 6 months was awarded one star
  3. bA cohort study with a follow-up rate > 75% was awarded one star